Published in Genome Med on April 09, 2015
A population genetics perspective on the determinants of intra-tumor heterogeneity. Biochim Biophys Acta (2017) 0.76
Genome evolution in ductal carcinoma in situ: invasion of the clones. J Pathol (2016) 0.75
Genome-wide reconstruction of complex structural variants using read clouds. Nat Methods (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47
Primer3--new capabilities and interfaces. Nucleic Acids Res (2012) 20.34
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med (2012) 13.49
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer (2004) 12.35
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet (2014) 5.74
Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am (2007) 4.66
Intratumor heterogeneity: evolution through space and time. Cancer Res (2012) 3.45
Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest (2011) 1.99
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol (2012) 1.78
Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res (2011) 1.52
PIK3CA mutations in in situ and invasive breast carcinomas. Cancer Res (2010) 1.49
Cancer. Heterogeneity and tumor history. Science (2012) 1.45
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. Breast Cancer Res Treat (2009) 1.45
Genome evolution during progression to breast cancer. Genome Res (2013) 1.37
Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int J Oncol (2006) 1.09
Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation? Clin Cancer Res (2009) 1.05
Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Mod Pathol (2013) 0.92
Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Pathol (2012) 0.92
A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome Biol (2014) 0.91
Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA. Mod Pathol (2013) 0.87